GVR Report cover Nicotine Gum Market Size, Share & Trends Report

Nicotine Gum Market Size, Share & Trends Analysis Report By Type (2mg, 4mg), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, Pharmacies, Online), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68040-043-7
  • Number of Pages: 110
  • Format: Electronic (PDF)

Report Overview

The global nicotine gum market was estimated at USD 1.30 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2023 to 2030. The demand for nicotine replacement therapy (NRT) products, including nicotine gum, has been increasing globally in recent years as more people are opting for methods to quit smoking and reduce their exposure to the harmful chemicals found in tobacco smoke. Some of the latest trends in the global NRT market include the development of more convenient and effective NRT products, such as long-lasting gums, and the growing popularity of flavored options. In addition, there has been an increase in the number of people using NRT products to quit smoking, as well as a rise in the number of healthcare professionals recommending NRT products to their patients.

U.S. nicotine gum market size, by type, 2020 - 2030 (USD Million)

The COVID-19 pandemic had a significant impact on the nicotine gum market. The lockdowns and restrictions imposed during the pandemic caused a significant increase in stress and anxiety levels among people, leading to a rise in smoking and nicotine use. As a result, the demand for nicotine gum and other nicotine replacement therapy (NRT) products increased as people opted for ways to quit smoking or manage their nicotine cravings.

The pandemic caused disruptions to supply chains, resulting in temporary shortages of some NRT products, including nicotine gum. This led to price hikes and difficulties in obtaining certain products, which created challenges for smokers who were trying to quit.

Moreover, the growing recognition of nicotine replacement therapy, including nicotine gum, as a safe and effective way to quit smoking has led to increased demand for these products. In addition, manufacturers are also investing in marketing & promoting nicotine and in R&D to create new and improved nicotine gum products. This includes the development of products with new flavors, enhanced efficacy, and more convenient delivery systems, which contribute to market expansion. Healthcare providers are also increasingly recommending and prescribing nicotine replacement therapy, including nicotine gum, to quit smoking.

Governments around the world have also recognized the role that NRT can play in helping people quit smoking and have taken steps to support its use. Many countries have included NRT products, such as nicotine gum, as part of their smoking cessation programs and have provided funding for research. For instance, Japan offers smoking cessation drugs & therapy which is available to all and is reimbursable under the National Health Insurance. In addition, some governments have implemented regulations to make NRT products more widely available and accessible to those who need them. The FDA is a regulatory authority in the U.S. that governs approval for the marketing of new drugs for human use under the United States Federal Food, Drug, and Cosmetic Act 1938.

Type Insights

The 2mg segment dominated the market and accounted for the largest revenue share of 55.9% in 2022. People consume 2mg of nicotine gums as a form of nicotine replacement therapy (NRT) to help them quit smoking or to reduce their cigarette consumption. There is a growing awareness of the health risks associated with smoking, which has led to an increase in the number of people looking for ways to quit or reduce their smoking.

The 4mg segment is projected to grow at a CAGR of 6.0% during the forecast period. People who consume 4mg of nicotine gum are typically heavy smokers, meaning they smoke 25 or more cigarettes per day. The higher dose of nicotine in the 4mg gum is intended to help smokers manage their nicotine cravings and withdrawal symptoms more effectively, as heavy smokers typically require a higher dose of nicotine to achieve relief.

Distribution Channel Insights

The pharmacies segment dominated the market and accounted for the largest revenue share of 38.4% in 2022. People buy nicotine gum from pharmacies for the medical advice and support available, the convenience of purchasing it along with other health-related products, the availability of the product, the quality of the product, and the confidentiality it offers. Moreover, pharmacies are staffed by trained professionals who can provide advice and information about nicotine gum and other nicotine replacement products.

Global nicotine gum market share, by distribution channel, 2022 (%)

The online distribution channel segment is estimated to grow at a CAGR of about 6.9% during the forecast period. This segment has witnessed immense popularity over the past few years. The shift in consumer preference toward online channels is due to the convenience that the channel provides, such as high discounts, availability of a diverse range of products on a single platform, easy payment methods, on-door delivery, and others. Additionally, online retailers often carry a large variety of nicotine gums with different flavors, strengths, and brands, compared to traditional brick-and-mortar stores. It allows consumers to choose the product that best fits their needs.

Regional Insights

North America dominated the nicotine gum market and accounted for the largest revenue share of 29.9% in 2022. The percentage of health-conscious consumers in North America has increased as a result of campaigns and government initiatives that have stimulated market growth in the region. In addition, the region is home to notable brands like Johnson & Johnson, Cipla Health Limited, Philip Morris, and others that prioritize product innovation in order to meet the market's growing demand and gain a competitive edge.

Nicotine Gum Market Trends, by Region, 2023 - 2030

Asia Pacific is expected to witness a CAGR of 6.5% from 2023 to 2030. This factor is attributable to the increasing demand for innovative products, the intensifying competition among the major tobacco companies, and the expansion of market opportunities, particularly in Japan. In addition, stringent anti-smoking regulations in India and China are anticipated to increase the demand for nicotine replacement products such as gums.

Key Companies & Market Share Insights

The industry is characterized by the presence of some large multinational and regional companies. Leading manufacturers hold a significant market share across the globe. Companies have been implementing various expansion strategies such as mergers & acquisitions, and capacity expansions, to stay competitive.

In July 2021, Philip Morris acquired nicotine gum manufacturer Fertin Pharma from a private equity firm for USD 813.1 million in an effort to expand its smoke-free portfolio. Fertin Pharma's products include tablets, chewing gums, and powders with pharmaceutical and nutraceutical applications that help people quit smoking.

In May 2019, Nicorette introduced a nicotine gum product coated with ice mint lozenge for a smoother mouthfeel. Some of the prominent players in the global nicotine gum market include:

  • Johnson & Johnson

  • Novartis AG

  • ITC Limited

  • Cipla Health Limited

  • Perrigo Company Plc.

  • Teva Canada

  • Philip Morris

  • British American Tobacco PLC

Nicotine Gum Market Report Scope

Report Attribute

Details

Market size value in 2023

USD 1365.7 million

Revenue forecast in 2030

USD 2.0 billion

Growth Rate

CAGR of 5.6% from 2023 to 2030

Base year for estimation

2022

Historical data

2017 - 2021

Forecast period

2023 - 2030

Quantitative units

Revenue in USD million, CAGR from 2023 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, trends

Segments covered

Type, distribution channel, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; China; Japan; India; South Korea; Brazil; Mexico; Argentina; UAE; South Africa

Key companies profiled

Johnson & Johnson; Novartis AG; ITC Limited; Cipla Health Limited; Perrigo Company Plc.; Teva Canada; Philip Morris; British American Tobacco PLC

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Global Nicotine Gum Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global nicotine gum market report based on type, distribution channel, and region:

Global Nicotine Gum Market Report Segmentation

  • Nicotine Gum Type Outlook (Revenue, USD Million, 2017 - 2030)

    • 2mg

    • 4mg

  • Nicotine Gum Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

    • Supermarkets/Hypermarkets

    • Convenience Stores

    • Pharmacies

    • Online

  • Nicotine Gum Regional Outlook (Revenue, USD Million, 2017 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • India

      • Japan

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East & Africa

      • UAE

      • South Africa

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon